Biogen, Inc. (BIIB)
197.10
+4.02
(+2.08%)
USD |
NASDAQ |
May 27, 16:00
196.45
-0.65
(-0.33%)
After-Hours: 17:08
Biogen Market Cap : 29.10B for May 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 181.40B |
| Gilead Sciences, Inc. | 166.01B |
| AbbVie, Inc. | 380.58B |
| Apellis Pharmaceuticals, Inc. (DELISTED) | 5.253B |
| Moderna, Inc. | 18.89B |
Market Cap Related Metrics
| PE Ratio | 21.15 |
| PS Ratio | 3.023 |
| Price to Book Value | 1.560 |
| Price to Free Cash Flow | 12.53 |
| Price | 197.10 |
| Earnings Yield | 4.73% |
| Operating PE Ratio | 12.66 |
| Normalized PE Ratio | 17.37 |